NuGene Announced That US Weekly Recently Reported That Sofia Vergara Used Nugene’s Universal Serum as Part of Her Skin Regimen in Preparation for Her Wedding to Joe Manganiello
IRVINE, Calif.–(BUSINESS WIRE)–Two of Hollywood’s hottest celebrities, Sofia Vergara and Joe
Manganiello, exchanged vows on November 22, 2015 in one of the year’s
most anticipated weddings. US Weekly recently interviewed the modern
family star’s NYC dermatologist and NuGene advisory board member Dr.
Dendy Engelman to find out how the mega-celebrity was preparing for her
big day. As part of the four-week beauty plan, US Weekly reported that
Sofia Vergara used NuGene’s Universal Serum.
“The science speaks for itself and we are honored that Sofia Vergara
trusted NuGene’s Universal Serum to help her skin look its best in
anticipation of her big wedding day,” said Ali Kharazmi founder and CEO
of NuGene International, Inc.
The entire interview with Dr. Dendy Engelman can be found here: http://www.usmagazine.com/celebrity-beauty/news/sofia-vergara-wedding-how-shes-prepping-her-skin-w158036
About Dr. Dendy Engelman
Dr. Engelman is a board certified dermatologic surgeon and an associate
at Manhattan Dermatology & Cosmetic Surgery. She is a fellow of the
American Academy of Dermatology, American Society of Dermatologic
Surgery and American College of Mohs Surgery (a procedure that removes
skin cancer under local anesthetic).
Most recently, Dr. Engelman was appointed Director of Dermatologic
Surgery at New York Medical College where she oversees the training of
future Mohs surgeons and dermatologists. Dr. Engelman also serves as a
scientific advisory board member of NuGene and consultant to numerous
pharmaceutical companies including Genetech, Allergen, Galderma, Merz
and L’Oreal.
About NuGene International, Inc.
NuGene International, Inc. specializes in developing, manufacturing and
marketing proprietary regenerative cosmeceutical and pharmaceutical
products based on adipose derived human stem cell and human stem cell
media. The US Department of Health and Human Services calls regenerative
medicine the “next evolution of medical treatments.” The regenerative
medical market (which includes cosmeceuticals and pharmaceuticals) was
estimated at $7.2 Billion in the US in 2014 and is expected to grow
rapidly in the coming years according to RNCOS Business Consultancy
Service Global Cosmeceuticals Market report.
NuGene’s cosmeceutical and pharmaceutical products are based on
proprietary stem cell based regenerative formulations derived from
non-controversial, adult human stem cell derived media obtained from
adipose tissue. NuGene’s exclusive products combine its in-house
advancements, proprietary technologies, and patent pending formulations.
The company has four patents pending covering 15 unique applications.
NuGene’s goal is to leverage its knowledge and expertise to develop
age-defying cosmeceutical skincare and hair care products in addition to
pharmaceutical products based on the same regenerative science platform.
Contacts
NuGene International, Inc.
Ali Kharazmi, CEO
949-468-5116
